Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease

Several single-center studies have confirmed the usability of cerebrospinal fluid (CSF) biomarkers for the diagnosis of Alzheimer's disease (AD), even in early disease stages. Large scale multicenter studies have principally confirmed this, although such studies have also indicated the presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, Niklas, Zetterberg, Henrik, Blennow, kaj
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915803/
https://www.ncbi.nlm.nih.gov/pubmed/20721354
http://dx.doi.org/10.4061/2010/610613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915803/
https://www.ncbi.nlm.nih.gov/pubmed/20721354
http://dx.doi.org/10.4061/2010/610613

Ejemplares similares